LAMISIL cpr 125 mg 14 pce
7680513060314
CH-51306
D01BA02
08.06.0.
1 / 3
google
Details
- Product number
- 5130601
- CPT
- -
- Packaging group
- 14
- Unit
- Tablette(n)
- Composition
- terbinafinum 125 mg ut terbinafini hydrochloridum, carboxymethylamylum natricum A corresp. natrium max. 1 mg, lactosum monohydricum 21.0 mg, cellulosum microcristallinum hypromellosum, magnesii stearas, pro compresso.
Articles (1)
Lamisil 125 mg, Tabletten
Tabletten
14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
125.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
21.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 39.75
Specialties list
Yes
Generic
No
SL addition date:
15/03/1995
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 51306
- Drug name
- Lamisil, Tabletten
- Galenic form
- TAB
- ATC Code
- D01BA02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 27/08/1991
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LAMISIL cpr 125 mg 14 pce
- Description (DE)
- LAMISIL Tabl 125 mg 14 Stk
- Market launch
- 27/08/1991
- Narcotic (BTM)
- No